Skip to main content
NIH funding notice RFA-DK-20-008

George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)

Closed on November 4, 2020.

Posted
June 3, 2020
Close date
November 4, 2020
Activity codes
U54
Institutes taking part
NIDDK

The notices it replaced

6 notices since 2012, oldest first, each with its awards since FY2014.

  1. Posted 2012RFA-DK-12-009None since FY2014
  2. Posted 2013RFA-DK-13-0202 awards
  3. Posted 2014RFA-DK-15-0022 awards
  4. Posted 2015RFA-DK-16-0131 award
  5. Posted 2017RFA-DK-17-013None since FY2014
  6. Posted 2019RFA-DK-18-0292 awards
  7. Posted 2020RFA-DK-20-008This notice, closed · 2 awards

Replaced by RFA-DK-28-314.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
9
6 new, 3 renewals
Median first-year cost
$1,200,000
$10,192,634 in all
Institutions
6
6 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES3
  2. UNIVERSITY OF WISCONSIN-MADISON2
  3. ENDEAVOR HEALTH CLINICAL OPERATIONS1
  4. STANFORD UNIVERSITY1
  5. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1

and 1 other institution

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-3 (O1))4
  2. Special Emphasis Panel (ZDK1 GRB-7 (O2))2
  3. Special Emphasis Panel (ZDK1 GRB-T (M3))2
  4. Special Emphasis Panel (ZDK1 GRB-3 (O2))1
9 awards under RFA-DK-20-008 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2021Investigating the Genetic, Cellular, and Metabolic Events Important for Urothelial Homeostasis and Response to Injury2U54DK104309-08Barasch, Jonathan M.Gharavi, Ali GMendelsohn, Cathy LeeCOLUMBIA UNIVERSITY HEALTH SCIENCES, NYFirst-year cost $1,200,000Study section ZDK1
FY2021Stanford O'Brien Urology Research Center1U54DK130065-01Brooks, James D.STANFORD UNIVERSITY, CAFirst-year cost $1,200,000Study section ZDK1
FY2019Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction2U54DK104310-06 · under RFA-DK-18-029Ricke, William AUNIVERSITY OF WISCONSIN-MADISON, WIFirst-year cost $1,200,000Study section ZDK1
FY2019Investigating the Genetic, Cellular, and Metabolic Events Important for Urothelial Homeostasis and Response to Urinary Tract Infection2U54DK104309-06 · under RFA-DK-18-029Barasch, Jonathan M.Gharavi, Ali GMendelsohn, Cathy LeeCOLUMBIA UNIVERSITY HEALTH SCIENCES, NYFirst-year cost $1,200,000Study section ZDK1
FY2016University of Pittsburgh O'Brien Cooperative Research Center Program1U54DK112079-01 · under RFA-DK-16-013Wang, ZhouUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PAFirst-year cost $1,525,532Study section ZDK1
FY2015Mechanisms of BPH Progression1U54DK104280-01A1 · under RFA-DK-15-002Fowke, Jay H.Hayward, Simon WENDEAVOR HEALTH CLINICAL OPERATIONS, ILFirst-year cost $240,000Study section ZDK1
FY2015Mechanisms of Bladder Urothelium-Nervous System Interactions in Health and Disease1U54DK104279-01A1 · under RFA-DK-15-002Andriole, Gerald LouisWASHINGTON UNIVERSITY, MOFirst-year cost $240,000Study section ZDK1
FY2014Mediators of fibrosis in the development of lower urinary tract dysfunction1U54DK104310-01 · under RFA-DK-13-020Ricke, William AUNIVERSITY OF WISCONSIN-MADISON, WIFirst-year cost $1,697,102Study section ZDK1
FY2014The Genetic Origins and Complications of Urinary Tract Abnormalities1U54DK104309-01 · under RFA-DK-13-020Barasch, Jonathan M.Gharavi, Ali GMendelsohn, Cathy LeeCOLUMBIA UNIVERSITY HEALTH SCIENCES, NYFirst-year cost $1,690,000Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.